telmisartan has been researched along with Ureteral Obstruction in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Li, H; Long, H; Luo, C; Peng, F; Wang, Y; Xu, Z; Yin, B | 1 |
Chen, JA; Gill, AJ; Gross, S; Jarolimek, W; Pollock, CA; Saad, S; Schilter, H; Wong, M; Wong, MG; Zhang, J | 1 |
Azuma, J; Iekushi, K; Iwabayashi, M; Kusunoki, H; Morishita, R; Okayama, K; Otsu, R; Rakugi, H; Sanada, F; Taniyama, Y | 1 |
Kira, S; Kobayashi, M; Maeshima, Y; Makino, H; Masuoka, N; Sugiyama, H; Sunami, R; Wang, DH; Yamasaki, Y | 1 |
4 other study(ies) available for telmisartan and Ureteral Obstruction
Article | Year |
---|---|
[Effect of telmisartan on expression of metadherin in the kidney of mice with unilateral ureter obstruction].
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Extracellular Matrix Proteins; Fibrosis; Kidney; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Random Allocation; RNA-Binding Proteins; RNA, Small Interfering; Telmisartan; Transforming Growth Factor beta1; Ureteral Obstruction | 2019 |
Semicarbazide-sensitive amine oxidase (SSAO) inhibition ameliorates kidney fibrosis in a unilateral ureteral obstruction murine model.
Topics: Amine Oxidase (Copper-Containing); Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; Kidney; Kidney Diseases; Mice, Inbred C57BL; Semicarbazides; Telmisartan; Ureteral Obstruction | 2014 |
Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
Topics: Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Antibodies; Benzimidazoles; Benzoates; Cells, Cultured; Disease Models, Animal; Fibroblasts; Hepatocyte Growth Factor; Hydronephrosis; Kidney; Losartan; Male; Mice; Mice, Knockout; PPAR gamma; Receptor, Angiotensin, Type 1; Signal Transduction; Telmisartan; Transforming Growth Factor beta; Ureteral Obstruction | 2012 |
Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice.
Topics: Acatalasia; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Fibrosis; Immunohistochemistry; In Situ Nick-End Labeling; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Mice; Mice, Inbred C3H; Mice, Mutant Strains; NADPH Oxidases; Oxidative Stress; Telmisartan; Treatment Outcome; Ureteral Obstruction | 2005 |